Inamed SEC probe update
This article was originally published in The Gray Sheet
Executive Summary
Securities and Exchange Commission staffers recommend halting the investigation of Inamed's disclosures for its silicone gel-filled breast implants, after advising that no enforcement action be taken, the firm reports in a Nov. 9 10-K filing. The firm has repeatedly claimed it is in compliance with federal securities laws since the probe began in February (1"The Gray Sheet" March 21, 2005, In Brief)...